BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37832224)

  • 1. Synthesis, characterization, in vitro antimycobacterial and cytotoxicity evaluation, DFT calculations, molecular docking and ADME studies of new isomeric benzimidazole-1,2,3-triazole-quinoline hybrid mixtures.
    Nyoni NTP; Ncube NB; Kubheka MX; Mkhwanazi NP; Senzani S; Singh T; Tukulula M
    Bioorg Chem; 2023 Dec; 141():106904. PubMed ID: 37832224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Quinoline-Urea-Benzothiazole Hybrids as Promising Antitubercular Agents: Synthesis, In Vitro Antitubercular Activity, Cytotoxicity Studies, and In Silico ADME Profiling.
    Moodley R; Mashaba C; Rakodi GH; Ncube NB; Maphoru MV; Balogun MO; Jordan A; Warner DF; Khan R; Tukulula M
    Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 1,2,3-Triazole-Containing Quinoline-Benzimidazole Hybrids: Synthesis, Antiproliferative Activity, In Silico ADME Predictions, and Docking.
    Krstulović L; Mišković Špoljarić K; Rastija V; Filipović N; Bajić M; Glavaš-Obrovac L
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular hybridization approach for phenothiazine incorporated 1,2,3-triazole hybrids as promising antimicrobial agents: Design, synthesis, molecular docking and in silico ADME studies.
    Reddyrajula R; Dalimba U; Madan Kumar S
    Eur J Med Chem; 2019 Apr; 168():263-282. PubMed ID: 30822714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antimycobacterial activity of 1-(β-d-Ribofuranosyl)-4-coumarinyloxymethyl- / -coumarinyl-1,2,3-triazole.
    Srivastava S; Bimal D; Bohra K; Singh B; Ponnan P; Jain R; Varma-Basil M; Maity J; Thirumal M; Prasad AK
    Eur J Med Chem; 2018 Apr; 150():268-281. PubMed ID: 29529504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular hybrids of substituted phenylcarbamoylpiperidine and 1,2,4-triazole methylacetamide as potent 15-LOX inhibitors: Design, synthesis, DFT calculations and molecular docking studies.
    Nawaz Z; Riaz N; Saleem M; Iqbal A; Abida Ejaz S; Bashir B; Muzaffar S; Ashraf M; Aziz-Ur-Rehman ; Sajjad Bilal M; Krishna Prabhala B; Sajid S
    Bioorg Chem; 2024 Feb; 143():106984. PubMed ID: 38056389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrazone-Tethered 5-(Pyridin-4-yl)-4H-1,2,4-triazole-3-thiol Hybrids: Synthesis, Characterisation, in silico ADME Studies, and in vitro Antimycobacterial Evaluation and Cytotoxicity.
    Oderinlo OO; Jordaan A; Seldon R; Isaacs M; Hoppe HC; Warner DF; Tukulula M; Khanye SD
    ChemMedChem; 2023 Mar; 18(6):e202200572. PubMed ID: 36617507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities.
    Yan X; Lv Z; Wen J; Zhao S; Xu Z
    Eur J Med Chem; 2018 Jan; 143():899-904. PubMed ID: 29227930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triazole based novel molecules as potential therapeutic agents: Synthesis, characterization, biological evaluation, in-silico ADME profiling and molecular docking studies.
    Şahin İ; Çeşme M; Özgeriş FB; Tümer F
    Chem Biol Interact; 2023 Jan; 370():110312. PubMed ID: 36535312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity profile of novel triazole/quinoline hybrids.
    Jamshidi H; Naimi-Jamal MR; Safavi M; RayatSanati K; Azerang P; Tahghighi A
    Chem Biol Drug Des; 2022 Dec; 100(6):935-946. PubMed ID: 35147277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid imidazole (benzimidazole)/pyridine (quinoline) derivatives and evaluation of their anticancer and antimycobacterial activity.
    Mantu D; Antoci V; Moldoveanu C; Zbancioc G; Mangalagiu II
    J Enzyme Inhib Med Chem; 2016; 31(sup2):96-103. PubMed ID: 27250919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of antibacterial and antioxidant activity of novel 2-phenyl-quinoline analogs derivatized at position 4 with aromatically substituted 4H-1,2,4-triazoles.
    Verbanac D; Malik R; Chand M; Kushwaha K; Vashist M; Matijašić M; Stepanić V; Perić M; Paljetak HČ; Saso L; Jain SC
    J Enzyme Inhib Med Chem; 2016; 31(sup2):104-110. PubMed ID: 27319400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
    Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
    Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity.
    Sirim MM; Krishna VS; Sriram D; Unsal Tan O
    Eur J Med Chem; 2020 Feb; 188():112010. PubMed ID: 31893548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential synthesis of amino-1,4-naphthoquinone-appended triazoles and triazole-chromene hybrids and their antimycobacterial evaluation.
    Devi Bala B; Muthusaravanan S; Choon TS; Ashraf Ali M; Perumal S
    Eur J Med Chem; 2014 Oct; 85():737-46. PubMed ID: 25129868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
    Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of a novel quinoline-triazole analogs for antitubercular properties via molecular hybridization approach.
    Ramprasad J; Kumar Sthalam V; Linga Murthy Thampunuri R; Bhukya S; Ummanni R; Balasubramanian S; Pabbaraja S
    Bioorg Med Chem Lett; 2019 Oct; 29(20):126671. PubMed ID: 31526604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinoline-imidazole/benzimidazole derivatives as dual-/multi-targeting hybrids inhibitors with anticancer and antimicrobial activity.
    Diaconu D; Antoci V; Mangalagiu V; Amariucai-Mantu D; Mangalagiu II
    Sci Rep; 2022 Oct; 12(1):16988. PubMed ID: 36216981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzimidazole and piperidine containing novel 1,2,3-triazole hybrids as anti-infective agents: Design, synthesis, in silico and in vitro antimicrobial efficacy.
    Mendapara JV; Vaghasiya MD; Rajani DP; Ahmad I; Patel H; Kumari P
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23526. PubMed ID: 37668402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional and microwave-assisted synthesis of new indole-tethered benzimidazole-based 1,2,3-triazoles and evaluation of their antimycobacterial, antioxidant and antimicrobial activities.
    Ashok D; Gundu S; Aamate VK; Devulapally MG
    Mol Divers; 2018 Nov; 22(4):769-778. PubMed ID: 29671194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.